- Home
- EMBJ vs AXSM Comparison
EMBJ vs AXSM Comparison
Compare EMBJ & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EMBJ | AXSM |
|---|---|---|
| Founded | 1969 | 2012 |
| Country | Brazil | United States |
| Employees | 25037 | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 12.0B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | EMBJ | AXSM |
|---|---|---|
| Price | $57.57 | $236.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 17 |
| Target Price | $84.00 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 1.8M | 811.6K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $57.24 |
| Revenue Next Year | $13.60 | $55.88 |
| P/E Ratio | $159.30 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $53.91 | $96.09 |
| 52 Week High | $80.75 | $235.92 |
Technical Indicators
Market Signals| Indicator | EMBJ | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 73.42 |
| Support Level | $54.54 | $179.00 |
| Resistance Level | $65.81 | N/A |
| Average True Range (ATR) | 2.17 | 7.06 |
| MACD | -0.45 | -0.03 |
| Stochastic Oscillator | 25.03 | 95.81 |
Price Performance
Historical ComparisonAbout EMBJ Embraer S.A.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment. Geographically, the company operates in Brazil, Europe, Asia Pacific, North America, and Others.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.